Obesity and increased fat mass are associated with increased adipocyte proliferation. Telomere length can serve as a biomarker of a cell's biological (vs chronological) age. To gain insight in the physiology of adipose tissue, we aimed to investigate telomere length in subcutaneous adipose tissue in relation to age and obesity. Telomere length was measured in 72 subcutaneous adipose tissue samples from 21 nonobese and 51 obese subjects. Telomere length of subcutaneous adipose tissue cells was negatively associated with body mass index (BMI), systolic blood pressure and fasting triglycerides. After controlling for age, fasting glucose, triglycerides and smoking status, BMI (P ¼ 0.009) contributed independently to 16% of telomere length variance. Interestingly, formerly obese patients (n ¼ 10) had shorter telomere length than never-obese subjects (n ¼ 12) of similar age, sex and BMI (7.1 ± 1.3 vs 9.08 ± 1.8 kb, P ¼ 0.01). In summary, adipose tissue cells from obese subjects show a shorter telomere length. The shorter telomere length of formerly obese subjects suggests that this is an established, irreversible feature of obesity that could contribute to its comorbidities.
Introduction
Adipose tissue has a central role in the management of systemic energy stores as well as in many other processes. This is because of its capacity to store triglycerides and its ability to secrete many proteins that have a major impact on energy homeostasis. A common observation in several lipoatrophic or lipodystrophic models is that in the absence of functional adipocytes, triglycerides tend to be stored ectopically in liver and muscle. These tissular and circulating lipids have been closely linked to insulin resistance. In mouse models with uninhibited expansion of adipose tissue and in pharmacological models in which an effective expansion of fat mass can be accomplished, such as in the context of the PPARg agonists, a healthy metabolic profile is attained despite excess body fat mass. These studies suggest that one of the key factors that link excess caloric intake and a positive energy balance with metabolic disturbance is the inability to expand the adipose tissue appropriately. [1] [2] [3] Telomeres are DNA-protein complexes that cap chromosomal ends, promoting chromosomal stability. When cells divide, the telomere is not fully replicated because of limitations of the DNA polymerases in completing the replication of the ends of the linear molecules, leading to telomere shortening with every replication. Without telomere protection, chromosome ends activate DNA damage response pathways that signal cell-cycle arrest, senescence or apoptosis. [4] [5] [6] Short telomeres in peripheral blood have been described in obese and diabetic patients and in individuals with cardiovascular risk factors, that is, increased blood pressure, increased carotid intima media thickness, smoking as well as in response to psychosocial stress. [7] [8] [9] [10] Telomere length, in vivo as well as in vitro, can be considered as a biological marker for age-and stress-related conditions. The mean telomere length of adipose tissue cells could be a marker of adipose tissue expandability. If this is the case, a failure to maintain telomere length should be linked to those metabolic disturbances associated with the relative inability to expand the adipose tissue appropriately. The aim of this study was to investigate telomere length of subcutaneous adipose tissue cells in association with obesity and associated morbidities.
Participants and methods

Participant recruitment
Seventy-two adipose tissue samples were obtained from subcutaneous depots (23 men and 49 women) during elective surgical procedures (cholecystectomy, surgery of abdominal hernia and gastric bypass surgery), washed, fragmented and immediately flash-frozen in liquid nitrogen before be stored at À80 1C.
All patients underwent a clinical assessment including medical history, physical examination, comorbidity evaluation as well as nutritional interviews performed by a multidisciplinary consultation team. Prescription of a diet providing a daily energy deficit of 500-1000 kcal per day was provided to those subjects scheduled for gastric bypass surgery (n ¼ 51), leading to significant weight loss (from 48.2 ± 6.5 to 41.9 ± 8.4 kg m À2 , Po0.0001). In these subjects we analyzed the influence of preweight loss body mass index (BMI) (BMI maximum ) and BMI at surgery (current BMI).
All subjects were of Caucasian origin. Exclusion criteria for those patients are detailed in Supplementary Data (1). All subjects gave written informed consent after the purpose of the study was explained to them. The hospital ethics committee approved the protocol.
Anthropometric measurements and analytical determinations are explained in Supplementary Data (2).
DNA purification from subcutaneous adipose tissue Total DNA purification from subcutaneous adipose tissue was performed using the phenol-chloroform method. Frozen adipose subcutaneous tissue was homogenized with lysis buffer containing Proteinase K for 30 s. The homogenate was incubated at 56 1C for 1 h and centrifuged at 13 000 g at 4 1C for 15 min. The infranatant fraction was added and mixed in phenol/chloroform/isoamil solution, and centrifuged at 5000 g at 4 1C for 15 min. Total DNA was quantified by means of spectrophotometer (GeneQuant; GE Healthcare, Piscataway, NJ, USA).
Telomere length measure Telomere length was measured by Telo TAGGG Telomere Length Assay (Roche, Penzberg, Germany), according to the manufacturer's instructions. Purified genomic DNA was digested by an optimized mixture of frequently cutting restriction enzymes, which digested to low-molecular-weight fragments nontelomeric DNA. Following DNA digestion, the DNA fragments were separated by gel electrophoresis and transferred to a nylon membrane by Southern blotting. The blotted DNA fragments were hybridized to a digoxigenin (DIG)-labeled probe specific for telomeric repeats and incubated with a DIG-specific antibody covalently coupled to alkaline phosphatase. Finally, the immobilized telomere probe was visualized by alkaline phosphatase metabolizing CDP-Star, a highly sensitive chemiluminescence substrate.
The average terminal restriction fragment length was determined by comparing the signals relative to a molecular weight standard. The intra-assay and inter-assay coefficients of variation were 4 and 12%, respectively.
Statistical analysis
Unpaired and paired t-tests and Pearson's correlation were used to evaluate the differences or associations between continuous variables. Multiple regression models were used to assess the influence of selected variables on telomere length. Levels of statistical significance were set at Po0.05.
Results
Anthropometric and clinical characteristics of all participants are shown in Table 1 . Telomere length of subcutaneous adipose tissue cells was negatively associated with BMI ( Figure 1) , systolic blood pressure and fasting triglycerides ( Table 2 ). In obese subjects telomere length was significantly shorter than nonobese subjects (7.1±1.6 vs 8.55±1.8 kb, P ¼ 0.002). The negative association between telomere length and BMI was maintained in both groups separately, in subjects with morbid obesity (r ¼ À0.41, P ¼ 0.01) and after excluding these subjects (r ¼ À0.47, P ¼ 0.005).
In both lean and obese subjects the skewness was near to zero (0.428±0.5 in lean subjects and 0.598±0.33 in obese subjects), although the skewness value in obese subjects was almost twice its standard error, indicating a departure from symmetry.
In multiple linear regression analysis, we found that age (P ¼ 0.04) and BMI (P ¼ 0.009) were independently associated with telomere length variance, after controlling for the effects of sex, age, fasting glucose, triglycerides and smoking status. When systolic blood pressure was added to the model, we found that BMI (P ¼ 0.02) and systolic blood pressure (P ¼ 0.03) were independently associated with telomere length variance. Telomere length and obesity JM Moreno-Navarrete et al
We observed that the telomere length of the adipose tissue cells was more closely related to the maximum BMI attained than to BMI at surgery. For this reason, we compared obese subjects (n ¼ 10) that had lost weight before the surgery (À34.4±10.8% of BMI, formerly obese subjects) with nevermorbidly obese subjects (n ¼ 12) of similar age (47.1 ± 12.9 vs 46.2 ± 7.2 years, 0.8), sex (3 vs 5 men) and BMI (29.99 ± 3.5 vs 27.7±4.8 kg m
À2
, P ¼ 0.2). Telomere length was significantly shorter in the former (7.1±1.3 vs 9.08±1.8 kb, P ¼ 0.01) than in the latter subjects (Figure 1) . In a multiple linear regression analysis, being formerly obese independently contributed to 29.2% (P ¼ 0.03) of telomere length variance after controlling for age and current BMI.
Discussion
Obesity and increased fat mass are associated with increased adipocyte proliferation. Telomere length can serve as a biomarker of a cell's biological (vs chronological) age or potential for further cell division. 6, 11 For these reasons we hypothesized Figure 1 (Left panel) Linear relationship between telomere length and body mass index (BMI) in all subjects (empty symbols, morbidly obese subjects (r ¼ À0.41, P ¼ 0.01) and filled symbols, nonmorbidly obese subjects (r ¼ À0.47, P ¼ 0.005)). (Right panels) Comparison of BMI, age and telomere length between never-obese and formerly obese subjects. Telomere length and obesity JM Moreno-Navarrete et al that shortening telomere length in subcutaneous adipose tissue could be an adipose tissue expansion marker. To the best of our knowledge, no previous study has evaluated telomere length of subcutaneous adipose tissue cells. BMI was an independent predictor of telomere length even after controlling for age and other confounding variables. In vitro, when telomeres shorten sufficiently, the cell is arrested into senescence. 6 A shorter telomere length in subcutaneous adipose tissue cells could reflect the relative increase in adipocyte number (the cell-number expansion or cell proliferation) that is higher in obese than in lean subjects during childhood and adolescence. 12 The proportion of newborn adipocytes added each year of life has been shown to be the same in obese and nonobese subjects. 12 The shorter telomeres would be thus reminiscent of this adipocyte number expansion during childhood and adolescence, which is unmodifiable after weight loss once the individual reaches the adult age. Furthermore, shorter telomere length in subcutaneous adipose tissue might reflect obesity-associated metabolic disorders, given its association with fasting triglycerides and systolic blood pressure. This observation was in line with our hypothesis: that a failure to maintain telomere length could be behind those metabolic disturbances linked to the relative inability of appropriately expanding adipose tissue.
Even after weight loss, formerly obese subjects showed a shorter telomere length than never-morbidly obese subjects participants. Formerly obese subjects are known to show other established features of fat metabolism such as blunted fat oxidation. 13 Together with lower resting energy expenditure, the failure to use fat as fuel has been postulated to contribute to a positive fat balance and weight gain in formerly obese subjects. 13 Nonadipose cells present in adipose tissue may have a different turnover rate and contribute to the differences observed between obese and nonobese subjects. The distribution of telomere lengths might vary in adipose tissue from obese subjects, which is more heterogeneous and consists of multiple cell types.
In summary, telomere length in subcutaneous adipose tissue is significantly shorter in obese and formerly obese subjects. Further research to evaluate the complex response involved in the maintenance of telomere integrity of adipose cells and its relationship with obesity is required.
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